D
Sell
2/3/2025Upgraded
Aimei Health Technology Co., Ltd (AFJK) was upgraded to D from D- on 2/3/2025 due to a large increase in the growth index, valuation index and volatility index. Operating cash flow increased 78.96% from -$256.2 to -$53.9, EBIT increased 35.3% from -$309.1 to -$200, and earnings per share increased from $0.0675 to $0.0824.
D
Sell
10/2/2024Upgraded
Aimei Health Technology Co., Ltd (AFJK) was upgraded to D- from E+ on 10/2/2024 due to a significant increase in the efficiency index, valuation index and volatility index.
E
Sell
7/1/2024Upgraded
Aimei Health Technology Co., Ltd (AFJK) was upgraded to E+ from E on 7/1/2024 due to a major increase in the total return index, valuation index and volatility index.
E
Sell
4/17/2024None
Aimei Health Technology Co., Ltd (AFJK) was downgraded to E from U on 04/17/2024.